The future of liver transplantation for viral hepatitis.

about

Management of portal hypertension before and after liver transplantation.Bioengineering considerations in liver regenerative medicine.Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2

P2860

Q38655675-67EFD53B-BECB-4EE4-8EEC-D28EE6E7467C Q47093789-681AB072-51DB-4AE4-8E7D-9BBC766F5D3B Q57492151-B23EA3FC-10C6-473C-AC46-3EF108ABA146

P2860

The future of liver transplantation for viral hepatitis.

Item

http://www.wikidata.org/entity/Q38774864

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The future of liver transplantation for viral hepatitis.

@en

type

Item

label

The future of liver transplantation for viral hepatitis.

@en

prefLabel

The future of liver transplantation for viral hepatitis.

@en

P1476

The future of liver transplantation for viral hepatitis

@en

P2093

François Durand

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic renal failure after transplantation of a nonrenal organ

The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients.

Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

The International Liver Transplant Society Guideline on Living Liver Donation.

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.

Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.

Report of the Paris consensus meeting on expanded criteria donors in liver transplantation.

High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.

P304

130-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.13310

http://www.w3.org/2001/XMLSchema#string

P478

37 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Claire Francoz

Francois Durand

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28052618

http://www.w3.org/2001/XMLSchema#string

The future of liver transplantation for viral hepatitis.

about

P2860

P2860

The future of liver transplantation for viral hepatitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698